Emerging Topic Conference: Controversies and Consensus in Alcohol-Associated Liver Disease

Course Description

Alcohol-associated liver disease (ALD) is the leading indication for liver related morbidity, mortality and need for liver transplantation. Alcoholic hepatitis (AH) is a severe form of ALD with a high short-term mortality. The AASLD Emerging Topic Conference: Controversies and Consensus in Alcohol-Associated Liver Disease combines the ALD and Liver Transplant Surgery SIGs to develop a combined one and half day program to discuss emerging trends and updates on the disease burden, current treatment options, and future therapies with a focus on updates on early liver transplantation for ALD and AH.

When & Where

Date: Saturday, October 1, 8:00 am - Sunday, October 2, 12:00 pm (EDT)
Location: Philadelphia Marriott Downtown 1201 Market Street Philadelphia, PA 19107
Continuing Education Credits: Continuing Medical Education (CME): 9.50 AMA PRA Category 1 Credits™ ABIM MOC points: 9.50 MOC points

Program Chairs

  • Gene Y. Im, MD
  • Anji Wall, MD, PhD
  • Sumeet K. Asrani, MD, MSc
  • Ashwani K. Singal, MD, MS, FACG, FAASLD

Location

Philadelphia Marriott Downtown
1201 Market Street
Philadelphia, PA 19107 

Reserve your hotel today!

Travel Note

US residents: Please review the Real ID Act regarding boarding federally regulated commercial aircrafts. Due to circumstances resulting from the COVID-19 pandemic, the Department of Homeland Security has extended the REAL ID enforcement deadline to May 3, 2023. Depending on your state of residence, you may need to provide a second form of identification at the airport.

Health and Safety Information

AASLD is taking steps to protect the health and safety of all stakeholders participating in the Emerging Topic Conference. This meeting will be happening in a public space and AASLD cannot guarantee that participants will not encounter members of the public who have not been fully vaccinated.

AASLD continues to ask all attendees, guests and AASLD staff to follow all applicable regulations and make informed choices about travel, onsite, and external engagement.

AASLD is monitoring the evolving public health guidance and AASLD will continue to update this page as new information becomes available.  AASLD asks all stakeholders to follow all applicable regulations and make informed choices about their participation in one or both in-person conferences offered.

The AASLD Governing Board has approved a “Vaccination Required” policy for all attendees and AASLD staff.

Schedule Note

Breakfast is served at 7:00 am ET both days.

Program Agenda

 

Session I: Burden of Alcohol-Associated Liver Disease

Moderators: Ashwani K. Singal, MD, MS, FACG, FAASLD and Ramon Bataller, MD, PhD

  • 8 am – 8:05 am    
    Introduction
    Ashwani K. Singal, MD, MS, FACG, FAASLD
  • 8:05 am – 8:25 am    
    Epidemiology and Cost of AH/ALD Care in U.S.
    Juan Pablo Arab, MD
  • 8:25 am – 8:45 am    
    The Role of Genetics in Alcohol-Use Disorders and Alcohol-Related Liver Disease: Moving Towards Translation
    Marsha Y. Morgan, FRCP
  • 8:45 am – 9:05 am    
    Hannes Hagstrom: new title: Diagnosis and Outcomes of Different Spectrums of Early ALD
    Hannes Hagström, MD, PhD
  • 9:05 am – 9:25 am    
    Diagnosis of AH
    Deepika Devuni, MBBS
  • 9:25 am – 9:45 am     
    Alcoholic Hepatitis: SIRS, ACLF, and Infections
    Shiv K. Sarin, MD, DM, DSc
  • 9:45 am – 10:05 am    
    Panel Discussion/Q&A
  • 10:05 am – 10:30 am    
    Break

Session II: Prediction and Therapy for AH

Moderators: Alex Louvet, MD, PhD, and Deepika Devuni, MBBS

  • 10:30 am – 10:50 am     
    Current Therapies of AH 
    Loretta Jophlin, MD, PhD
  • 10:50 am – 11:10 am     
    Emerging and Novel Therapeutic Targets 
    Ashwani K. Singal, MD, MS, FACG, FAASLD
  • 11:10 am – 11:30 am    
    Estimating Prognosis: Current Scores and Biomarkers 
    Allison J. Kwong, MD
  • 11:30 am – 11:50 am    
    Future and Emerging Biomarkers: Diagnosis, Prognosis, and Treatment Response 
    Ramon Bataller, MD, PhD
  • 11:50 am – 12:10 pm    
    Panel Discussion/Q&A
  • 12:10 pm – 1 pm    
    Lunch

Session III: Management of Alcohol Use Disorder

Moderators: Allison J. Kwong, MD, and Lorenzo Leggio, MD, PhD

  • 1 pm – 1:20 pm    
    Management of AUD in Patients with ALD 
    Lamia Haque, MD, MPH
  • 1:20 pm – 1:40 pm    
    Integrating AUD and ALD Care: Multidisciplinary Management with Addiction Specialists 
    Jessica L. Mellinger, MD
  • 1:40 pm – 2 pm    
    Panel Discussion/Q&A
  • 2 pm – 2:20 pm    
    Break

Session IV: LT for AH/ALD

Moderators: Sumeet K. Asrani, MD, MSc and Gene Y. Im, MD

  • 2:20 pm – 2:40 pm    
    LT in ALD: Unique Pre- and Post-transplant Issues 
    Michael R. Lucey, MD, FAASLD 
  • 2:40 pm – 3 pm    
    Benefits and Current Status of Early LT in AH / ALD 
    Alex Louvet, MD, PhD
  • 3 pm – 3:20 pm    
    LDLT for AH in India and Eastern Countries 
    Mohamed Rela, MBBS, FRCS, DSc
  • 3:20 pm – 3:40 pm    
    US Experience in Early Liver Transplantation for Alcohol-Associated Hepatitis: Results from the ACCELERATE-AH Consortium
    Brian P. Lee, MD
  • 3:40 pm – 4 pm    
    Panel Discussion/Q&A
  • 4 pm – 4:05 pm    
    Wrap-up: Day One
    Gene Y. Im, MD

Session V: Optimizing Candidate Selection in ALD and AH

Moderators: Vijay Shah, MD, FAASLD and Michael Lucey, MD, FAASLD

  • 8 am – 8:05 am    
    Introduction
    Ashwani K. Singal, MD, MS, FACG, FAASLD
  • 8:05 am – 8:25 am     
    Ethical Considerations and Pitfalls of Early LT in AH 
    Anji Wall, MD, PhD
  • 8:25 am – 8:45 am    
    Slippery Slope of Early LT for AH-dangers and Unintended Consequences 
    James F. Trotter, MD
  • 8:45 am – 9:05 am    
    Standardizing Multidisciplinary Care and Patient Selection for LT for AH 
    Norah Terrault, MD, MPH, FAASLD
  • 9:05 am – 9:25 am    
    Panel Discussion/Q&A
  • 9:25 am – 9:45 am     
    Break

Session VI: Next Steps in LT for AH

Moderators: Norah Terrault, MD, MPH, FAASLD and Alex Louvet, MD, PhD

  • 9:45 am – 10:05 am     
    Proposals and Implications for Standard Reporting in UNOS 
    Scott W. Biggins, MD, MAS, FAASLD
  • 10:05 am – 10:25 am     
    Standardizing Post-transplant Monitoring and Management of AUD 
    Lorenzo Leggio, MD, PhD
  • 10:25 am – 10:45 am     
    Putting it All Together: Clinical Trial Designs 
    Vijay Shah, MD, FAASLD
  • 10:45 am – 11:25 am    
    Putting it All Together: Transplant Committee Simulation: Cases and Consensus 
    Gene Y. Im, MD
  • 11:25 am – 11:45 am    
    Panel Discussion/Q&A
  • 11:45 am – 11:50 am    
    Wrap-up and Adjourn
    Sumeet K. Asrani, MD, MSc

Registration Pricing

General

Any physician, scientist, or researcher with doctoral-level training who is not employed by Industry (pharma/device/etc.)

Member Non-Member
Rate $340 $570

Trainee & Associate

Any physician, scientist or researcher in a training program as certified by the director of their training program. This category also includes, but is not limited to, the degrees of MS, NP, PA, RN, and other related or comparable degrees.

Member Non-Member
Rate $195 $245

Student

Member Non-Member
Rate $95 $120

Industry

Industry
Rate $815

Patient Advocates & Caregivers

Registration scholarships are available by request for the patient advocate and patients and caregivers categories. Please contact Michael Providence, Senior Manager, Patient Engagement at mprovidence@aasld.org for more information.

Patient Advocate Patient Caregiver
Rate $25 $25

Registration Cancellation Policy

Requests for cancellations must be submitted in writing to meetings@aasld.org.

Cancellations received by Tuesday, August 30, 2022 will be refunded in full.

Cancellations received between August 31 – September 19, 2022 will be subject to a $50.00 cancellation fee.

Cancellations received on or after September 20, 2022 are not eligible for a refund

Continuing Education

Continuing Medical Education (CME)

The American Association for the Study of Liver Diseases (AASLD) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. AASLD designates this live activity for a maximum of 9.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Board of Internal Medicine Maintenance of Certification (MOC) 

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 9.50 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points.

CME Credits

Physicians and other health care professionals seeking AMA PRA Category 1 Credits™ for this live continuing medical education activity must complete an evaluation by Tuesday, November 15. A link to the CME evaluation will be emailed to attendees after the meeting.

MOC Points

Physicians seeking ABIM MOC points must complete the CME and MOC evaluation by Tuesday, November 15.  Requests for MOC after this date will not be honored.  The MOC evaluation is included in the CME evaluation. 

MOC Points will be reported to the ABIM by the end of November 2022 for attendees who successfully complete the MOC evaluation. 

Needs Statement

Alcohol-associated liver disease (ALD) is the leading indication for liver related morbidity, mortality and need for liver transplantation. Alcoholic hepatitis (AH) is a severe form of ALD with a high short-term mortality. This ETC combines the ALD and Liver Transplant Surgery SIGs to develop a combined one and half day program to discuss emerging trends and updates on the disease burden, current treatment options, and future therapies with a focus on updates on early liver transplantation for ALD and AH.

Learning Objectives

Upon completion of this activity, learners will be able to:

  • Understand the disease burden of ALD and its current and future pharmacological treatments.  
  • Recognize the unmet need of multidisciplinary care of ALD patients with hepatology and addiction teams.  
  • Understand the status and emerging trends on the role of early liver transplant in patients with life-threatening ALD, including severe AH.

  • Hepatologists    
  • Gastroenterologists    
  • Nurses
  • Nurse Practitioners    
  • Physician Assistants    
  • Transplant Coordinators
  • Surgeons
  • Pharmacists    
  • Fellows/Trainees    
  • Patient Advocacy Groups

This activity was planned in the context of the following ACGME/IOM/IPEC competencies: 
Patient Care and Procedural Skills; Provide Patient-centered Care; Values/Ethics for Interprofessional Practice; Medical Knowledge; Work in Interdisciplinary Teams; Roles/Responsibilities; Practice-based Learning and Improvement; Employ Evidence-based Practice; Interprofessional Communication; Interpersonal and Communication Skills; Apply Quality Improvement; Teams and Teamwork; Professionalism; Utilize Informatics; Systems-based Practice

Housing

Venue

Philadelphia Marriott Downtown
1201 Market Street 
Philadelphia, PA 19107
Phone: 215-625-2900 
Reserve your hotel today! 
*When you are calling to make a reservation, please let the hotel representative know you are attending the AASLD Emerging Topic Conference.

Rates

Single/Double $279 per night plus tax

Cancellation Policy

All hotel room reservations must be cancelled at least 72 hours (local time) in advance to avoid a one-night room penalty.

Airport

Philadelphia International Airport (PHL)

Ground Transportation

Shuttle Services

Shuttle services are not provided by the Philadelphia Marriott Downtown hotel. 

Taxi

From PHL the taxi fare estimation is $30.  This estimation is for a one-way fare. 

Public Transportation

The estimated metro fare from PHL to the Jefferson Street station is $8. 

Parking

The daily valet parking fee is $57.50. There is limited onsite parking during special events and weekends.